AMENDMENT NO. 1 TO AGREEMENT NO. 00135085BETWEEN AMGEN USA INC. AND DAVITA INC.Agreement • November 4th, 2022 • Amgen Inc • Biological products, (no disgnostic substances)
This Amendment No. 1 (“Amendment No. 1”) to that certain Sourcing and Supply Agreement No. 00135085 (the “Agreement”) is made and entered into by and between Amgen USA Inc. (“Amgen”) and DaVita Inc. (“Dialysis Center”). This Amendment No. 1 shall be effective on January 1, 2023 (the “Amendment No. 1 Date”).
